"insufficient clinical benefit"
50 patients and insufficient clinical benefit , if they get hundreds of patients over next few years its going to be the same result is it not. $10m cash left is less than a years capital if they need to do more trials. FDA approval would need even more trials.
Ann: CE Marking Update, page-96
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.001(5.00%) |
Mkt cap ! $41.62M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $74.12K | 6.919M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 12365078 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 1002313 | 8 |
View Market Depth
| Last trade - 14.47pm 22/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |